
Sign up to save your podcasts
Or


Vinod Thourani and Matthew Price review the 2-year outcomes of the TRILUMINATE trial and discuss clinical progression among the control group.
By Heart Valve CollaboratoryVinod Thourani and Matthew Price review the 2-year outcomes of the TRILUMINATE trial and discuss clinical progression among the control group.